Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mesa Laboratories (MLAB) EBITDA Margin (2016 - 2025)

Mesa Laboratories' EBITDA Margin history spans 16 years, with the latest figure at 12.25% for Q4 2025.

  • For Q4 2025, EBITDA Margin rose 305.0% year-over-year to 12.25%; the TTM value through Dec 2025 reached 6.96%, up 11481.0%, while the annual FY2025 figure was 6.78%, 13263.0% up from the prior year.
  • EBITDA Margin for Q4 2025 was 12.25% at Mesa Laboratories, up from 7.78% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 12.25% in Q4 2025 and bottomed at 460.55% in Q1 2024.
  • The 5-year median for EBITDA Margin is 5.61% (2024), against an average of 19.59%.
  • The largest annual shift saw EBITDA Margin crashed -45536bps in 2024 before it skyrocketed 46292bps in 2025.
  • A 5-year view of EBITDA Margin shows it stood at 4.59% in 2021, then skyrocketed by 236bps to 6.27% in 2022, then crashed by -102bps to 0.13% in 2023, then skyrocketed by 7440bps to 9.2% in 2024, then skyrocketed by 33bps to 12.25% in 2025.
  • Per Business Quant, the three most recent readings for MLAB's EBITDA Margin are 12.25% (Q4 2025), 7.78% (Q3 2025), and 5.15% (Q2 2025).